Insulin Infusion Sets: A Critical Reappraisal
- PMID: 26885764
- DOI: 10.1089/dia.2016.0013
Insulin Infusion Sets: A Critical Reappraisal
Abstract
An insulin infusion set (IIS) is a key component of insulin pumps. In daily practice issues with the IIS appear to be as relevant for a successful insulin therapy as the pumps themselves. The insulin is applied to the subcutaneous tissue via a Teflon(®) (Dupont, Wilmington, DE) or steel cannula. There are intensive discussions about the impact the choice of material for insulin application has on insulin pharmacokinetics. In this review, this factor and others that are known to have an impact on the successful usage of IIS are discussed.
Similar articles
-
Impact of Infusion Set Materials and Designs on the Subcutaneous Response in People With Diabetes: A Rapid Review of the Literature.J Diabetes Sci Technol. 2023 Mar;17(2):314-321. doi: 10.1177/19322968221138076. Epub 2022 Nov 18. J Diabetes Sci Technol. 2023. PMID: 36398844 Free PMC article. Review.
-
Insulin Infusion Set Use: European Perspectives and Recommendations.Diabetes Technol Ther. 2016 Sep;18(9):517-24. doi: 10.1089/dia.2016.07281.sf. Epub 2016 Aug 15. Diabetes Technol Ther. 2016. PMID: 27526329 Free PMC article.
-
Effect of steel and teflon infusion catheters on subcutaneous adipose tissue blood flow and infusion counter pressure in humans.Diabetes Technol Ther. 2009 May;11(5):301-6. doi: 10.1089/dia.2008.0061. Diabetes Technol Ther. 2009. PMID: 19425878
-
In vivo investigation of the tissue response to commercial Teflon insulin infusion sets in large swine for 14 days: the effect of angle of insertion on tissue histology and insulin spread within the subcutaneous tissue.BMJ Open Diabetes Res Care. 2019 Dec 8;7(1):e000881. doi: 10.1136/bmjdrc-2019-000881. eCollection 2019. BMJ Open Diabetes Res Care. 2019. PMID: 31875136 Free PMC article.
-
Pharmacokinetics of insulin. Implications for continuous subcutaneous insulin infusion therapy.Clin Pharmacokinet. 1985 Jul-Aug;10(4):303-14. doi: 10.2165/00003088-198510040-00002. Clin Pharmacokinet. 1985. PMID: 3899451 Review.
Cited by
-
A 4-Week, Two-Center, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of EOPatch in Well-Controlled Type 1 Diabetes Mellitus.Diabetes Metab J. 2022 Nov;46(6):941-947. doi: 10.4093/dmj.2021.0299. Epub 2022 Mar 8. Diabetes Metab J. 2022. PMID: 35255546 Free PMC article.
-
Tissue Response to Subcutaneous Infusion Catheter.J Diabetes Sci Technol. 2020 Mar;14(2):226-232. doi: 10.1177/1932296819837972. Epub 2019 Mar 31. J Diabetes Sci Technol. 2020. PMID: 30931603 Free PMC article.
-
Impact of Infusion Set Materials and Designs on the Subcutaneous Response in People With Diabetes: A Rapid Review of the Literature.J Diabetes Sci Technol. 2023 Mar;17(2):314-321. doi: 10.1177/19322968221138076. Epub 2022 Nov 18. J Diabetes Sci Technol. 2023. PMID: 36398844 Free PMC article. Review.
-
In Vivo Study of the Inflammatory Tissue Response Surrounding a Novel Extended-Wear Kink-Resistant Insulin Infusion Set Prototype Compared With a Commercial Control Over Two Weeks of Wear Time.J Diabetes Sci Technol. 2023 Nov;17(6):1563-1572. doi: 10.1177/19322968221093362. Epub 2022 May 9. J Diabetes Sci Technol. 2023. PMID: 35533132 Free PMC article.
-
Insulin Infusion Set Use: European Perspectives and Recommendations.Diabetes Technol Ther. 2016 Sep;18(9):517-24. doi: 10.1089/dia.2016.07281.sf. Epub 2016 Aug 15. Diabetes Technol Ther. 2016. PMID: 27526329 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical